Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Immupharma updates on successful placing

Drug discovery firm ImmuPharma has raised £7.7mln from the previously announced fundraise and is due to receive a further £0.7mln from advance assurances.
Immupharma updates on successful placing
It has applied to HMRC to receive VCT Advance Assurance and / or EIS Advance Assurances to raise the further £0.7mln but these must be obtained no later than March 23..

Drug discovery firm ImmuPharma (LON:IMM) has  raised £7.7mln from the previously announced fundraise and is due to receive a further £0.7mln from advance assurances.

It has applied to HMRC to receive VCT Advance Assurance and / or EIS Advance Assurances to raise the further £0.7mln but these must be obtained no later than March 23.

The firm has said the cash will be used to fund its share of the costs of developing Lupuzor, its potential blockbuster drug for the autoimmune disease Lupus, which is currently undergoing phase III clinical trials and also provide the firm with its working capital requirements through to 2018.

Immupharma shares eased 2.08% to 23.5p.

Giles_55af4ddca6481.jpg
Why Invest In ImmuPharma PLC? Read More Here

Register here to be notified of future IMM Company articles
View full IMM profile View Profile

ImmuPharma PLC Timeline

Related Articles

Proteomics International Laboratories: Access latest PPT from Proactive's CEO Sessions
April 13 2017
Richard Lipscombe talked revenue generation and growth path with investors.
cancer cells
January 24 2017
The US-based, London-listed healthcare group topped expectations with its latest results and analysts are tipping it for more success this year
Knee surgery
February 02 2017
The treatment involves removing cellular material from animal and human tissue to leave a matrix which gives a framework for population by the patient’s own cells.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use